2 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Staphylococcal Infections: new trials by email Literature Review of Staphylococcal Infections trials Research Report on Staphylococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis human lactoferrin peptide 1-11 - Staphylococcal Infections, Bacteremia | Phase 1 / Phase 2 | Withdrawn | AM-Pharma | 2009-02-01 | 2014-05-28 | |
| Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia ceftobiprole medocaril - Bacteremia | Phase 2 | Withdrawn | Basilea Pharmaceutica | 2013-02-20 |
Bacteremia (2) · Sepsis (1) · Toxemia (1)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Systemic Inflammatory Response Syndrome (2) · Sepsis (1)
ceftobiprole medocaril (1) · lactoferrin (1-11), human (1)
AM-Pharma (1) · Basilea Pharmaceutica (1)
Netherlands (1)